TreborRx
-
Moving forward with Trebor on their 100M mask agreement, ZEN achieves positive initial phase 2 cytotoxicity results
ZEN Graphene Solutions Ltd. (TSXV: ZEN) (‘ZEN’) continues to innovate and rapidly progress. Initially a graphite junior, then…
